Surendranath S. Shastri, M.B.B.S, M.D., D.Ph.
Department of Health Disparities Research, Division of Cancer Prevention and Population Sciences
Present Title & Affiliation
Primary Appointment
Professor, Department of Health Disparities Research, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
1990 | Tata Institute of Social Sciences (Deemed University), Mumbai, IND, DHA, Hospital Administration |
1985 | Seth G. S. Medical College, University of Mumbai, Mumbai, USA, MD, Medical Doctorate |
1984 | Seth G. S. Medical College, University of Mumbai, Mumbai, IND, DPH, Public Health |
1980 | Mahatma Gandhi Institute of Medical Sciences, University of Nagpur, Nagpur, IND, MBBS, Medicine and Surgery |
Experience & Service
Academic Appointments
Professor, Department of Population Health Research, BKL Walawalkar Rural Medical College and Hospital, Maharashtra, 2017 - 2018
Professor, Homi Bhabha National Institute, Mumbai, 2005 - 2016
Professor, Department of Preventive Oncology, Tata Memorial Center, Mumbai, 1997 - 2016
Assistant Professor, Seth G. S. Medical College and KEM Hospital, Mumbai, 1984 - 1990
Institutional Committee Activities
Co-Chair, Faculty Search Committee, Department of Health Disparities Research, Division of Cancer Prevention and Population Sciences, UTMDACC, 2019 - Present
Member, Institutional Review Board - 4, UTMDACC, 2019 - Present
Member, Faculty Senate, UTMDACC, 2018 - Present
Member, Faculty Senate Research Affairs Committee, UTMDACC, 2018 - Present
Member, HPV Vaccination Initiative Control Advisory Panel, UTMDACC, 2018 - Present
Member, End Tobacco Working Group, UTMDACC, 2018 - Present
Military or Other Governmental Service
General Duty Medical Officer, Government of India, 1984 - 1984
Honors & Awards
2014 | Humanitarian Award, American Society of Clinical Oncology |
2014 | Hugh Barber Lectureship Award, Society of Gynecologic Oncology |
2008 | WHO Tobacco Control Award, World Health Organization |
2006 | International Achievement Award, American Cancer Society |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Mittra I, Mishra GA, Dikshit RP, Gupta S, Kulkarni VY, Shaikh HKA, Shastri SS, Hawaldar R, Gupta S, Pramesh CS, Badwe RA. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. BMJ 372:n256, 2021. e-Pub 2021. PMID: 33627312.
- Kamaraju S, Drope J, Sankaranarayanan R, Shastri S. Cancer Prevention in Low-Resource Countries: An Overview of the Opportunity. Am Soc Clin Oncol Educ Book 40:1-12, 2020. PMID: 32239989.
- Barr D, Chan D, Garfinkel S, Hammatt Z, Ichikawa I, Kalichman M, Lalani EN, Lee IJ, Leung F, Mah E, Mayer T, Palittapongarnpim P, Sawicka T, Sham MH, Shastri S, Sun P, Taylor P, Tzeng O. First meeting in Asia of the Asia Pacific Research Integrity network. Account Res 27(2):99-106, 2020. e-Pub 2020. PMID: 31937142.
- Anand KV, Pimple SA,Mishra GA, Sahare RV, Pathuthara S, Deodhar KK, Shastri SS.. Reliability of conventional Papanicolaou smear in diagnosing bacterial vaginosis among women with clinical genital infection, 2020. PMID: 31956611.
- Muwonge R, Basu P, Gheit T, Anantharaman D, Verma Y, Bhatla N, Joshi S, Esmy PO, Poli URR, Shah A, Zomawia E, Shastri SS, Pimple S, Prabhu PR, Hingmire S, Chiwate A, Sauvaget C, Lucas E, Malvi SG, Siddiqi M, Sankaran S, Kannan TPRA, Varghese R, Divate U, Vashist S, Mishra G, Jadhav R, Tommasino M, Pillai MR, Sankaranarayanan R, Jayant K, Indian HPV vaccine study group. Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study. PLoS One 15(12):e0244242, 2020. e-Pub 2020. PMID: 33373380.
- Jeronimo J, Castle PE, Temin S, Denny L, Gupta V, Kim JJ, Luciani S, Murokora D, Ngoma T, Qiao Y, Quinn M, Sankaranarayanan R, Sasieni P, Schmeler KM, Shastri SS. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline. J Glob Oncol 3(5):635-657, 2017. e-Pub 2016. PMID: 29094101.
- Castle PE, Jeronimo J, Temin S, Shastri SS. Screening to Prevent Invasive Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline. J Clin Oncol 35(11):1250-1252, 2017. e-Pub 2017. PMID: 28135111.
- Jeronimo J, Castle PE, Temin S, Shastri SS. Secondary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline Summary. J Oncol Pract 13(2):129-133, 2017. e-Pub 2016. PMID: 27845871.
- Jayant K, Sankaranarayanan R, Thorat RV, Muwonge R, Hingmire SJ, Panse NS, Shastri SS, Malvi SG, Nene B. Improved Survival of Cervical Cancer Patients in a Screened Population in Rural India. Asian Pac J Cancer Prev 17(11):4837-4844, 2016. e-Pub 2016. PMID: 28030908.
- Pimple S, Mishra G, Shastri S. Global strategies for cervical cancer prevention. Curr Opin Obstet Gynecol 28(1):4-10, 2016. PMID: 26642063.
- Mishra GA, Pimple SA, Shastri SS. Prevention of Cervix Cancer in India. Oncology 91 Suppl 1:1-7, 2016. e-Pub 2016. PMID: 27463969.
- Sankaranarayanan R, Prabhu PR, Pawlita M, Gheit T, Bhatla N, Muwonge R, Nene BM, Esmy PO, Joshi S, Poli UR, Jivarajani P, Verma Y, Zomawia E, Siddiqi M, Shastri SS, Jayant K, Malvi SG, Lucas E, Michel A, Butt J, Vijayamma JM, Sankaran S, Kannan TP, Varghese R, Divate U, Thomas S, Joshi G, Willhauck-Fleckenstein M, Waterboer T, Müller M, Sehr P, Hingmire S, Kriplani A, Mishra G, Pimple S, Jadhav R, Sauvaget C, Tommasino M, Pillai MR, Indian HPV Vaccine Study Group. Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study. Lancet Oncol 17(1):67-77, 2016. e-Pub 2015. PMID: 26652797.
- Mishra GA, Pimple SA, Shastri SS. HPV vaccine: One, two, or three doses for cervical cancer prevention?. Indian J Med Paediatr Oncol 36(4):201-6, 2015. PMID: 26811587.
- Mistry R, Pimple S, Mishra G, Gupta PC, Pednekar M, Ranz-Schleifer N, Shastri S. Compliance With Point-of-Sale Tobacco Control Policies in School-Adjacent Neighborhoods in Mumbai, India. Am J Health Promot. e-Pub 2015. PMID: 26389976.
- Rajaraman P, Anderson BO, Basu P, Belinson JL, Cruz AD, Dhillon PK, Gupta P, Jawahar TS, Joshi N, Kailash U, Kapambwe S, Katoch VM, Krishnan S, Panda D, Sankaranarayanan R, Selvam JM, Shah KV, Shastri S, Shridhar K, Siddiqi M, Sivaram S, Seth T, Srivastava A, Trimble E, Mehrotra R. Recommendations for screening and early detection of common cancers in India. Lancet Oncol 16(7):e352-61, 2015. PMID: 26149887.
- Mishra GA, Kulkarni SV, Gupta SD, Shastri SS. Smokeless tobacco use in Urban Indian women: Prevalence and predictors. Indian J Med Paediatr Oncol 36(3):176-82, 2015. PMID: 26681842.
- Majmudar VP, Mishra AG, Kulkarni VS, Dusane RR, Shastri SS. Tobacco-related knowledge, attitudes, and practices among urban low socioeconomic women in Mumbai, India. Indian J Med Paediatr Oncol 36(1):32-7, 2015. PMID: 25810572.
- Mishra GA, Dhivar HD, Gupta SD, Kulkarni SV, Shastri SS. A population-based screening program for early detection of common cancers among women in India - methodology and interim results. Indian J Cancer 52(1):139-45, 2015. PMID: 26838003.
- Krishnan S, Sivaram S, Anderson BO, Basu P, Belinson JL, Bhatla N, D'Cruz A, Dhillon PK, Gupta PC, Joshi N, Jhulka PK, Kailash U, Kapambwe S, Katoch VM, Kaur P, Kaur T, Mathur P, Prakash A, Sankaranarayanan R, Selvam JM, Seth T, Shah KV, Shastri S, Siddiqi M, Srivastava A, Trimble E, Rajaraman P, Mehrotra R. Using implementation science to advance cancer prevention in India. Asian Pac J Cancer Prev 16(9):3639-44, 2015. PMID: 25987015.
- Mishra GA, Kulkarni SV, Majmudar PV, Gupta SD, Shastri SS. Community-based tobacco cessation program among women in Mumbai, India. Indian J Cancer 51 Suppl 1:S54-9, 2014. PMID: 25526250.
- Shastri A, Shastri SS. Cancer screening and prevention in low-resource settings. Nat Rev Cancer 14(12):822-9, 2014. e-Pub 2014. PMID: 25355377.
- Pimple S, Gunjal S, Mishra GA, Pednekar MS, Majmudar P, Shastri SS. Compliance to Gutka ban and other provisons of COTPA in Mumbai. Indian J Cancer 51 Suppl 1:S60-6, 2014. PMID: 25526251.
- Muwonge R, Wesley RS, Nene BM, Shastri SS, Jayant K, Malvi SG, Thara S, Sankaranarayanan R. Evaluation of cytology and visual triage of human papillomavirus-positive women in cervical cancer prevention in India. Int J Cancer 134(12):2902-9, 2014. e-Pub 2013. PMID: 24272364.
- Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, Fan L, Li J, Chavarri-Guerra Y, Liedke PE, Pramesh CS, Badovinac-Crnjevic T, Sheikine Y, Chen Z, Qiao YL, Shao Z, Wu YL, Fan D, Chow LW, Wang J, Zhang Q, Yu S, Shen G, He J, Purushotham A, Sullivan R, Badwe R, Banavali SD, Nair R, Kumar L, Parikh P, Subramanian S, Chaturvedi P, Iyer S, Shastri SS, Digumarti R, Soto-Perez-de-Celis E, Adilbay D, Semiglazov V, Orlov S, Kaidarova D, Tsimafeyeu I, Tatishchev S, Danishevskiy KD, Hurlbert M, Vail C, St Louis J, Chan A. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol 15(5):489-538, 2014. PMID: 24731404.
- Mishra GA, Gunjal SS, Pimple SA, Majmudar PV, Gupta SD, Shastri SS. Impact of 'gutkha and pan masala ban' in the state of Maharashtra on users and vendors. Indian J Cancer 51(2):129-32, 2014. PMID: 25104193.
Grant & Contract Support
Title: | Cost-effectiveness analysis of breast cancer management |
Funding Source: | World Health Organization |
Role: | Principal Investigator |
Title: | Efficacy of 2 versus 3 doses of HPV vaccines, multi-center study |
Funding Source: | Bill and Melinda Gates Foundation |
Role: | Principal Investigator |
Title: | Cervical Cancer Prevention Project, Osmanabad, India |
Funding Source: | Bill and Melinda Gates Foundation |
Role: | Principal Investigator |
Title: | Early Detection of Common Cancers in Women in India |
Funding Source: | NIH/NCI |
Role: | Principal Investigator |
Title: | Evaluation of the diagnostic performance of HPV E6/E7 mRNA vs. oncogenic HPV DNA as secondary triage for VIA positive women in cervical cancer screening |
Funding Source: | DBT,Government of India |
Role: | Co-Investigator |
Title: | Concurrent Evaluation of 3 Oral Cancer Screening Methods: 1) Naked Eye Unaided Examination; 2) Examination with VELScope; and 3) Examination after application of Toluidine Blue, all performed by Trained Primary Health Workers, for the Early Detection of Oral Neoplasia |
Funding Source: | American Cancer Society (ACS) |
Role: | Principal Investigator |
Title: | Cervix Cancer Screening by 2-Step triage: primary screening by VIA and triage by HPV-DNA Test |
Funding Source: | American Cancer Society (ACS) |
Role: | Principal Investigator |
Title: | Phase II Randomized, Multicenter, Placebo Controlled Study on the Clearance of Human Papillomavirus Infection in Uterine Cervix by ‘Basant Polyherbal Cream’ in HPV Infected Women |
Funding Source: | DBT,Government of India |
Role: | Principal Investigator |
Title: | Comparative Evaluation of Early Detection of Cervical Cancer Precursors by Cytology, HPV testing, Visual Inspection with Acetic Acid (VIA) and with Lugol’s Iodine (VILI) |
Funding Source: | Bill and Melinda Gates Foundation |
Role: | Principal Investigator |
Title: | Global Youth Tobacco Survey (GYTS) |
Funding Source: | World Health Organization |
Role: | Principal Investigator |
Title: | Global School Personnel Survey (GSPS) |
Funding Source: | World Health Organization |
Role: | Principal Investigator |
Title: | Global Health Professional Student Survey (GHPSS) |
Funding Source: | World Health Organization |
Role: | Principal Investigator |
Title: | Assessment of the impact of Gutkha and Pan Masala Ban in Maharashtra |
Funding Source: | Public Health Foundation of India |
Role: | Co-Investigator |
Title: | Elucidation of the Relationship between HPV and Oesophageal Cancer and the Development of Immunoreactive Recombinant HPV-16 Capsid Protien-derived Virus12 like Particles/ Capsomeres to evaluate anti-HPV Antibody Status and to Assess Potential Vaccine Candidate |
Funding Source: | DAE, Government of India |
Role: | Co-Investigator |
Title: | Randomized intervention trial to evaluate single vs. double freeze cryotherapy in the prevention of cervical neoplasia |
Funding Source: | DAE, Government of India |
Role: | Co-Investigator |
Title: | Multi-country (China, Mexico, Brazil, India) Study on Determinants of Salivary Cotinine Levels in Smokers |
Funding Source: | Bloomberg School of Hygiene and Public Health |
Role: | Co-Principal Investigator |
Title: | Smokefree Mumbai Program |
Funding Source: | Bloomberg Philanthropies |
Role: | Principal Investigator |
Title: | Phase IIIB, Double Blind, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of GSK Biologicals HPV-16/18 L1 VLP/ASO4 Vaccine Administered Intramuscularly according to 0, 1, 6 Months Schedule in Healthy Female Indian Subjects aged 18-35 Year |
Funding Source: | GSK Biologicals |
Role: | Principal Investigator |
Title: | Smoke-free Public Housing in Larger Houston Area underserved African American Communities |
Funding Source: | State of Texas Tobacco Funds |
Role: | Principal Investigator |
Title: | SENSE Study - Focus Groups in India about Role of Education/Training on Cancer Prevention Uptake |
Funding Source: | American Association for Cancer Education (AACE) |
Role: | Principal Investigator |
Title: | Indo-US Cancer Prevention and Data Science Initiative |
Funding Source: | NIH/NCI |
Role: | Principal Investigator |
Title: | Smokefree Public Housing: Improving Compliance and Smoking Cessation in African American Housing Communities |
Funding Source: | NIH/NCI |
Role: | Principal Investigator |
Title: | Smokefree Public Housing in Texas: Improving Compliance and Cessation Support |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Principal Investigator |
Title: | A Model Family-based Intervention for Cervical Cancer Elimination in Public Housing Units in Texas |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Principal Investigator |
Title: | Eliminating Disparities through Neighborhood Access to Cervical Cancer Prevention |
Funding Source: | NIH/NCI |
Role: | Principal Investigator |